Gastrointestinal Stromal Tumor Treatment Market By Drug Class (Tyrosine Kinase Inhibitors (TKIs), Multikinase Inhibitors, Others) By Route of Administration (Oral, Injectable, Others) By End User (Hospitals, Specialty Clinics, Cancer Research Centers, Homecare Settings, Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Table of Content

• 1. Research Methodology and Data Source
  • 1.1. Methodology/Research Approach
  • 1.2. Market Size Estimation
  • 1.3. Market Breakdown and Data Triangulation
  • 1.4. Data Sources
  • 1.5. Secondary Sources
  • 1.6. Primary Sources
• 2. Executive Summary
  • 2.1. Taxonomy
  • 2.2. Global Market Outlook
  • 2.3. Key Facts and Figures
  • 2.4. Major Players in Gastrointestinal Stromal Tumor Treatment Market
• 3. Global Market Overview
  • 3.1. Industry Overview
  • 3.2. Segmental Overview
  • 3.3. Regional Overview
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
    • 3.4.4. Trends
  • 3.5. Regulatory Framework
  • 3.6. Opportunity Map Analysis
  • 3.7. Opportunity Orbits
  • 3.8. Market Investment Feasibility Index
  • 3.9. PESTLE Analysis
  • 3.10. PORTER’S Five Force Analysis
  • 3.11. Drivers & Restraints Impact Analysis
  • 3.12. Patient Journey Mapping
  • 3.13. Technological Landscape
  • 3.14. Product Life Cycle Analysis
  • 3.15. Value Chain Analysis
    • 3.15.1. List of Raw Material Suppliers
    • 3.15.2. List of Gastrointestinal Stromal Tumor Treatment Manufacturers
    • 3.15.3. List of Dealer/Distributors
    • 3.15.4. List of Potential Customers
  • 3.16. Cost Structure Analysis
  • 3.17. Regional Market Share and BPS Analysis
• 4. Macro-economic Factors
• 5. Impact of Current Geopolitical Scenario
• 6. Global Gastrointestinal Stromal Tumor Treatment Market Analysis and Forecast, By Drug Class
  • 6.1. Key Findings
  • 6.2. Global Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 6.2.1. Tyrosine Kinase Inhibitors (TKIs)
    • 6.2.2. Multikinase Inhibitors
    • 6.2.3. Others
  • 6.3. Global Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Drug Class
• 7. Global Gastrointestinal Stromal Tumor Treatment Market Analysis and Forecast, By Route of Administration
  • 7.1. Key Findings
  • 7.2. Global Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 7.2.1. Oral
    • 7.2.2. Injectable
    • 7.2.3. Others
  • 7.3. Global Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Route of Administration
• 8. Global Gastrointestinal Stromal Tumor Treatment Market Analysis and Forecast, By End User
  • 8.1. Key Findings
  • 8.2. Global Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 8.2.1. Hospitals
    • 8.2.2. Specialty Clinics
    • 8.2.3. Cancer Research Centers
    • 8.2.4. Homecare Settings
    • 8.2.5. Others
  • 8.3. Global Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By End User
• 9. Global Gastrointestinal Stromal Tumor Treatment Market Analysis and Forecast, By Region
  • 9.1. Key Findings
  • 9.2. Global Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Region, 2020-2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Middle East & Africa
    • 9.2.5. Latin America
  • 9.3. Global Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Region
• 10. North America Gastrointestinal Stromal Tumor Treatment Market Analysis and Forecast, 2020-2035
  • 10.1. Key Findings
  • 10.2. North America Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • 10.3. North America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Drug Class
  • 10.4. North America Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • 10.5. North America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Route of Administration
  • 10.6. North America Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  • 10.7. North America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By End User
  • 10.8. North America Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 10.9. North America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Country
    • 10.9.1. The US Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 10.9.2. The US Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 10.9.3. The US Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 10.9.4. Canada Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 10.9.5. Canada Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 10.9.6. Canada Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
• 11. Europe Gastrointestinal Stromal Tumor Treatment Market Analysis and Forecast, 2020-2035
  • 11.1. Key Findings
  • 11.2. Europe Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • 11.3. Europe Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Drug Class
  • 11.4. Europe Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • 11.5. Europe Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Route of Administration
  • 11.6. Europe Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  • 11.7. Europe Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By End User
  • 11.8. Europe Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 11.9. Europe Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Country
    • 11.9.1. Germany Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.2. Germany Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.3. Germany Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 11.9.4. The U.K. Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.5. The U.K. Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.6. The U.K. Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 11.9.7. France Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.8. France Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.9. France Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 11.9.10. Spain Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.11. Spain Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.12. Spain Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 11.9.13. Italy Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.14. Italy Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.15. Italy Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 11.9.16. Russia & CIS Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.17. Russia & CIS Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.18. Russia & CIS Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 11.9.19. Rest of Europe Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 11.9.20. Rest of Europe Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 11.9.21. Rest of Europe Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
• 12. Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Analysis and Forecast, 2020-2035
  • 12.1. Key Findings
  • 12.2. Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • 12.3. Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Drug Class
  • 12.4. Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • 12.5. Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Route of Administration
  • 12.6. Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  • 12.7. Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By End User
  • 12.8. Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 12.9. Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Country
    • 12.9.1. China Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.2. China Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.3. China Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 12.9.4. India Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.5. India Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.6. India Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 12.9.7. Japan Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.8. Japan Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.9. Japan Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 12.9.10. South Korea Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.11. South Korea Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.12. South Korea Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 12.9.13. ASEAN Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.14. ASEAN Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.15. ASEAN Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 12.9.16. Australia & New Zealand Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.17. Australia & New Zealand Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.18. Australia & New Zealand Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 12.9.19. Rest of Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 12.9.20. Rest of Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 12.9.21. Rest of Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 13. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Analysis and Forecast, 2020-2035
• 13.1. Key Findings
  • 13.2. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • 13.3. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Drug Class
  • 13.4. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • 13.5. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Route of Administration
  • 13.6. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  • 13.7. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By End User
  • 13.8. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 13.9. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Country
    • 13.9.1. GCC Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 13.9.2. GCC Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 13.9.3. GCC Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 13.9.4. South Africa Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 13.9.5. South Africa Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 13.9.6. South Africa Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 13.9.7. Rest of Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 13.9.8. Rest of Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 13.9.9. Rest of Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
• 14. Latin America Gastrointestinal Stromal Tumor Treatment Market Analysis and Forecast, 2020-2035
  • 14.1. Key Findings
  • 14.2. Latin America Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • 14.3. Latin America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Drug Class
  • 14.4. Latin America Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • 14.5. Latin America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Route of Administration
  • 14.6. Latin America Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
  • 14.7. Latin America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By End User
  • 14.8. Latin America Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 14.9. Latin America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Country
    • 14.9.1. Brazil Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 14.9.2. Brazil Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 14.9.3. Brazil Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 14.9.4. Mexico Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 14.9.5. Mexico Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 14.9.6. Mexico Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
    • 14.9.7. Rest of Latin America Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Drug Class, 2020-2035
    • 14.9.8. Rest of Latin America Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
    • 14.9.9. Rest of Latin America Gastrointestinal Stromal Tumor Treatment Market Size Value (US$ Bn) Forecast, By End User, 2020-2035
• 15. Competitive Landscape & Company Profiles
  • 15.1. Market Competition Scenario Analysis, By Company
  • 15.2. Competitor Landscape
  • 15.3. Company Share Analysis
  • 15.4. Company Profiles
    • 15.4.1. Novartis AG
      • 15.4.1.1. Company Details
      • 15.4.1.2. Business Overview
      • 15.4.1.3. Product Portfolio
      • 15.4.1.4. Financial Insights
      • 15.4.1.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.1.6. SWOT Analysis
      • 15.4.1.7. Geographic Footprint
    • 15.4.2. Pfizer Inc.
      • 15.4.2.1. Company Details
      • 15.4.2.2. Business Overview
      • 15.4.2.3. Product Portfolio
      • 15.4.2.4. Financial Insights
      • 15.4.2.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.2.6. SWOT Analysis
      • 15.4.2.7. Geographic Footprint
    • 15.4.3. Bayer AG
      • 15.4.3.1. Company Details
      • 15.4.3.2. Business Overview
      • 15.4.3.3. Product Portfolio
      • 15.4.3.4. Financial Insights
      • 15.4.3.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.3.6. SWOT Analysis
      • 15.4.3.7. Geographic Footprint
    • 15.4.4. Blueprint Medicines Corporation
      • 15.4.4.1. Company Details
      • 15.4.4.2. Business Overview
      • 15.4.4.3. Product Portfolio
      • 15.4.4.4. Financial Insights
      • 15.4.4.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.4.6. SWOT Analysis
      • 15.4.4.7. Geographic Footprint
    • 15.4.5. Deciphera Pharmaceuticals Inc.
      • 15.4.5.1. Company Details
      • 15.4.5.2. Business Overview
      • 15.4.5.3. Product Portfolio
      • 15.4.5.4. Financial Insights
      • 15.4.5.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.5.6. SWOT Analysis
      • 15.4.5.7. Geographic Footprint
    • 15.4.6. Johnson & Johnson
      • 15.4.6.1. Company Details
      • 15.4.6.2. Business Overview
      • 15.4.6.3. Product Portfolio
      • 15.4.6.4. Financial Insights
      • 15.4.6.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.6.6. SWOT Analysis
      • 15.4.6.7. Geographic Footprint
    • 15.4.7. Merck & Co., Inc.
      • 15.4.7.1. Company Details
      • 15.4.7.2. Business Overview
      • 15.4.7.3. Product Portfolio
      • 15.4.7.4. Financial Insights
      • 15.4.7.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.7.6. SWOT Analysis
      • 15.4.7.7. Geographic Footprint
    • 15.4.8. Bristol-Myers Squibb Company
      • 15.4.8.1. Company Details
      • 15.4.8.2. Business Overview
      • 15.4.8.3. Product Portfolio
      • 15.4.8.4. Financial Insights
      • 15.4.8.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.8.6. SWOT Analysis
      • 15.4.8.7. Geographic Footprint
    • 15.4.9. Eli Lilly and Company
      • 15.4.9.1. Company Details
      • 15.4.9.2. Business Overview
      • 15.4.9.3. Product Portfolio
      • 15.4.9.4. Financial Insights
      • 15.4.9.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.9.6. SWOT Analysis
      • 15.4.9.7. Geographic Footprint
    • 15.4.10. Roche Holding AG
      • 15.4.10.1. Company Details
      • 15.4.10.2. Business Overview
      • 15.4.10.3. Product Portfolio
      • 15.4.10.4. Financial Insights
      • 15.4.10.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.10.6. SWOT Analysis
      • 15.4.10.7. Geographic Footprint
    • 15.4.11. Sun Pharmaceutical Industries Ltd.
      • 15.4.11.1. Company Details
      • 15.4.11.2. Business Overview
      • 15.4.11.3. Product Portfolio
      • 15.4.11.4. Financial Insights
      • 15.4.11.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.11.6. SWOT Analysis
      • 15.4.11.7. Geographic Footprint
    • 15.4.12. Teva Pharmaceutical Industries Ltd.
      • 15.4.12.1. Company Details
      • 15.4.12.2. Business Overview
      • 15.4.12.3. Product Portfolio
      • 15.4.12.4. Financial Insights
      • 15.4.12.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.12.6. SWOT Analysis
      • 15.4.12.7. Geographic Footprint
    • 15.4.13. Mylan N.V. (Viatris)
      • 15.4.13.1. Company Details
      • 15.4.13.2. Business Overview
      • 15.4.13.3. Product Portfolio
      • 15.4.13.4. Financial Insights
      • 15.4.13.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.13.6. SWOT Analysis
      • 15.4.13.7. Geographic Footprint
    • 15.4.14. Cipla Inc.
      • 15.4.14.1. Company Details
      • 15.4.14.2. Business Overview
      • 15.4.14.3. Product Portfolio
      • 15.4.14.4. Financial Insights
      • 15.4.14.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.14.6. SWOT Analysis
      • 15.4.14.7. Geographic Footprint
    • 15.4.15. Dr. Reddy's Laboratories Ltd.
      • 15.4.15.1. Company Details
      • 15.4.15.2. Business Overview
      • 15.4.15.3. Product Portfolio
      • 15.4.15.4. Financial Insights
      • 15.4.15.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.15.6. SWOT Analysis
      • 15.4.15.7. Geographic Footprint

List of Tables

• Table 1: Global Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 2: Global Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 3: Global Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 4: Global Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Region, 2020-2035
• Table 5: North America Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 6: North America Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 7: North America Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 8: North America Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Country, 2020-2035
• Table 9: The US Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 10: The US Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 11: The US Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 12: Canada Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 13: Canada Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 14: Canada Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 15: Europe Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 16: Europe Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 17: Europe Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 18: Europe Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Country, 2020-2035
• Table 19: Germany Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 20: Germany Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 21: Germany Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 22: The U.K. Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 23: The U.K. Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 24: The U.K. Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 25: France Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 26: France Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 27: France Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 28: Spain Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 29: Spain Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 30: Spain Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 31: Italy Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 32: Italy Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 33: Italy Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 34: Russia & CIS Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 35: Russia & CIS Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 36: Russia & CIS Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 37: Rest of Europe Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 38: Rest of Europe Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 39: Rest of Europe Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 40: Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 41: Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 42: Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 43: Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Country, 2020-2035
• Table 44: China Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 45: China Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 46: China Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 47: India Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 48: India Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 49: India Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 50: Japan Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 51: Japan Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 52: Japan Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 53: South Korea Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 54: South Korea Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 55: South Korea Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 56: ASEAN Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 57: ASEAN Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 58: ASEAN Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 59: Australia & New Zealand Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 60: Australia & New Zealand Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 61: Australia & New Zealand Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 62: Rest of Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 63: Rest of Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 64: Rest of Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 65: Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 66: Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 67: Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 68: Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Country, 2020-2035
• Table 69: GCC Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 70: GCC Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 71: GCC Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 72: South Africa Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 73: South Africa Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 74: South Africa Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 75: Rest of Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 76: Rest of Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 77: Rest of Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 78: Latin America Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 79: Latin America Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 80: Latin America Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 81: Latin America Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Country, 2020-2035
• Table 82: Brazil Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 83: Brazil Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 84: Brazil Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 85: Mexico Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 86: Mexico Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 87: Mexico Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035
• Table 88: Rest of Latin America Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Drug Class, 2020-2035
• Table 89: Rest of Latin America Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By Route of Administration, 2020-2035
• Table 90: Rest of Latin America Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), By End User, 2020-2035

List of Figures

• Figure 1: Global Gastrointestinal Stromal Tumor Treatment Market Value (US$ Bn), 2020-2035
• Figure 2: Global Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Drug Class, 2025 & 2035
• Figure 3: Global Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Route of Administration, 2025 & 2035
• Figure 4: Global Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By End User, 2025 & 2035
• Figure 5: Global Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Region, 2025 & 2035
• Figure 6: Global Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 7: Global Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Drug Class
• Figure 8: Global Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 9: Global Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Route of Administration
• Figure 10: Global Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 11: Global Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By End User
• Figure 12: Global Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Region, 2020, 2025 and 2035
• Figure 13: Global Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Region
• Figure 14: North America Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 15: North America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Drug Class
• Figure 16: North America Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 17: North America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Route of Administration
• Figure 18: North America Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 19: North America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By End User
• Figure 20: North America Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 21: North America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Country
• Figure 22: Europe Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 23: Europe Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Drug Class
• Figure 24: Europe Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 25: Europe Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Route of Administration
• Figure 26: Europe Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 27: Europe Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By End User
• Figure 28: Europe Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 29: Europe Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Country
• Figure 30: Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 31: Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Drug Class
• Figure 32: Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 33: Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Route of Administration
• Figure 34: Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 35: Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By End User
• Figure 36: Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 37: Asia Pacific Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Country
• Figure 38: Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 39: Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Drug Class
• Figure 40: Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 41: Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Route of Administration
• Figure 42: Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 43: Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By End User
• Figure 44: Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 45: Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Country
• Figure 46: Latin America Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 47: Latin America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Drug Class
• Figure 48: Latin America Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 49: Latin America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Route of Administration
• Figure 50: Latin America Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 51: Latin America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By End User
• Figure 52: Latin America Gastrointestinal Stromal Tumor Treatment Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 53: Latin America Gastrointestinal Stromal Tumor Treatment Market Attractiveness Analysis, By Country